Medicines Division

Department of Internal Medicine, Division of Infectious Diseases, Washington University School of Medicine, 660 South Euclid Ave, St. Louis, MO, 63110, USA e-mail rklein id.wustl.edu... 

Assistant Professor Technology Development Coordinator Oregon Health Science University School of Medicine Division of Physician Assistant Education Portland, Oregon... 

John A. Belperio Department of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA Christopher C. Broder Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA Astrid E. Cardona Neuroinflammation Research Center, Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland,... 

Michael P. Keane Department of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA... 

Preventive Medicine Division, Office of The Surgeon General, Department of the Army, Washington, D. C. 

Department of Internal Medicine, Division of Allergy, Ann Arbor, Ml, USA... 

Global Research Institute of Management and Technology, Radaur, Yamuna Nagar, Haryana, India department of Chemistry, University of Cape Town, Rondebosch, 7700, South Africa, institute of Infectious Disease and Molecular Medicine, Division of Medical Biochemistry, University of Cape Town, Observatory, South Africa. 

University of North Carolina, School of Medicine, Division of Pulmonary Medicine, Chapel Hill, NC 27514... 

The CSD was serviced by a professional secretariat of pharmacists and medical officers who undertook the assessment of the submissions and presented these to the Committee and its various subcommittees. The secretariat initially included three doctors and two pharmacists. In 1965, the number of professional staff had been increased to six doctors and three pharmacists. Among the six doctors was Dr Denis Cahal, who headed the secretariat. Others were Drs J Broadbent, M Hollyhock, WH Inman, D Mansel-Jones and C Ruttle. The secretriat, known as the Medicines Division, was created as a branch of the Department of Health. The close collaboration between Dr Cahal and Sir Derrick Dunlop was pivotal in guiding the Medicines Act through Parliament in 1968 and setting the foundation of a system that became a model to the rest of the world for fairness and efficiency. 

The day-to-day administration of the Act for human medicines was delegated to the Medicines Division of the Department of Health and Social Security (DHSS) and was managed jointly by an Under Secretary and the professional head of the division. The professional head of the... 

Medicines Division held the rank of senior principal medical officer. 

Over the period, the successive professional heads of the Medicines Division have been Dr DA Cahal (1964-70), Dr D Mansel-Jones (1970-4), Dr EL Harris (1974-7), Dr JP Griffin (1977-84) and Dr G Jones (1984-9). In 1989, when the Medicines Division was reorganised into the Medicines Control Agency (MCA) (see section 16.7), Dr KH Jones was appointed the first Director of the new Agency. 

The European Union s advisory Committee, the CPMP, was set up in 1975 under Directive 75/319. The first meeting was held on 26 November 1976 and Mr Leon Robert from Luxembourg was appointed its first Chairman. The Professional Head of the then UK Medicines Division, Dr EL Harris, who was also the UK Representative to CPMP, was elected a Deputy Chairman. Dr JP Griffin, initially his alternate but later the UK representative during 1977-84, was appointed Chairman of the CPMP Working Party on Safety. Dr NMG Dukes from the Dutch regulatory... 

In 1975, a paper was produced by the Professional Head of Medicines Division of the Department of Health and Social Security (DHSSKnow DoH) for consideration by the Medicines Commission. It was proposed that a new style BNF should be produced because the DHSS was concerned that doctors were being unduly influenced by promotional material produced by the pharmaceutical industry that was leading to an escalating medicines bill for the NHS. It was suggested that the New Style BNF should fulfill the following criteria ... 

Visiting Professor, University of Surrey Postgraduate Medical School Former Director, Association of the British Pharmaceutical Industry, London Formerly Professional Head of the Medicines Division, DHSS, London... 

N. E. Chayen, Department of BioMolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics,... 

Barry Cusack, MD Chief, Geriatrics Section, VA Medical Center, 500 W Fort St, Boise, ID 83702-4598, USA, and Professor of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, WA 98195, USA... 

Associate Clinical Professor of Medicine, Division of Clinical Pharmacology and Toxicology, University of Colorado Health Sciences Center, Denver... 

Papanicolaou Cancer Research Institute, 1155 Northwest 14th St., Miami, Fla. 33136, and Department of Medicine, Division of Hematology, University of Miami School of Medicine, POB 875—Biscayne Annex, Miami, Fla. 33152... 

Department of Medicine, Division of Digestive Disease and Nutrition, J-214 JHMHC, University of Florida College of Medicine, Gainesville, FL 32610... 

Department of Molecular Physiology and Biophysics, Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, TX 77030... 

P.E.T. Facility, Nuclear Medicine Division, Department of Radiology, Duke University Medical Center, Durham, NC27710, U.S.A. 

Teresa P. Dilorenzo Department of Microbiology Immunology and Department of Medicine, Division of Endocrinology, Albert Einstein College of Medicine, Bronx,... 

Lloyd E. King, Jr. The Skin Disease Research Center, Department of Medicine, Division of Dermatology, Vanderbilt Medical Center, Nashville, TN, USA... 

---